Newsbot

Warburg Research belässt Einhell auf Buy - Ziel 105 Euro

HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat die Einstufung für Einhell nach Halbjahreszahlen auf "Buy" mit einem Kursziel von 105 Euro belassen. Umsatz und Vorsteuerergebnis seien knapp unter seinen Prognosen geblieben, schrieb Philipp Kaiser in einer am Dienstag vorliegenden Studie. [mehr]

Apple changes fees for alternative app stores in EU

Apple said on Tuesday it will charge a 5% commission on digital transactions in apps distributed outside its App Store, replacing a more complex system as it ?seeks to comply with the European Unions Digital Markets Act.

Idex (IEX) Upgraded to Buy: Heres Why

Idex (IEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Buy-back of shares in MTG during week 33, 2026

During the period between 10 August 2026 and 14[ ]August 2026 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 63 000 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 500 million, which MTG announced on 21 May 2026. The share repurchase program, which runs from 22 May 2026 up until and includin...
TUI AG

TUI Aktie zwischen Kursdruck und Shortseller-Rückzug: Jetzt entsteht eine brisante Börsenlage

Bad Marienberg (www.aktiencheck.de) - Bei der TUI-Aktie prallen derzeit zwei bemerkenswerte Signale aufeinander. Einerseits verliert das Papier aktuell 1,23 Prozent auf 7,062 Euro und steht damit unter Verkaufsdruck. Andererseits reduziert ausgerechnet einer der großen Shortseller sein Engagement: Capital Fund Management SA hat seine Netto-Leerverkaufsposition am 17. [mehr]

Watch CNBCs full interview with Hims & Hers CEO Andrew Dudum

In an exclusive interview, Hims & Hers CEO Andrew Dudum sits down with Squawk Box Co-Anchor Andrew Ross Sorkin and shares his perspective on how AI can transform healthcare, the companys transition from compound to brand name GLP-1s, and his vision to bring down the cost of healthcare.

Zalando Aktie: Neue Short-Attacke trifft auf fallenden Kurs

Bad Marienberg (www.aktiencheck.de) - Die Zalando-Aktie bleibt ein heißes Pflaster für Anleger: Während der Kurs aktuell um 0,70 Prozent auf 22,62 Euro nachgibt, verschärft ein prominenter Shortseller seine Wette auf fallende Notierungen. PDT Partners, LLC hat seine Netto-Leerverkaufsposition am 17. August 2026 von 1,09 Prozent auf 1,11 Prozent erhöht. [mehr]

Urology Care Foundation Names Dr. Aisha Siebert 2026 Health Equity Fellow

Pediatric urology fellow will explore barriers to fertility preservation access for children and adolescents and develop solutions to improve equitable care Pediatric urology fellow will explore barriers to fertility preservation access for children and adolescents and develop solutions to improve equitable care

Lightspeed Launches AI Command Center™

Industry-first conversational AI built directly into Lightspeed DMS turns live dealership data into immediate, actionable answers Industry-first conversational AI built directly into Lightspeed DMS turns live dealership data into immediate, actionable answers

K+S Aktie: Millennium verschwindet unter die Meldeschwelle - doch die Shortseller sind längst nicht weg

Bad Marienberg (www.aktiencheck.de) - Bei der K+S-Aktie sendet ein prominenter Shortseller ein interessantes Signal: Millennium International Management LP hat seine Netto-Leerverkaufsposition am 17. August 2026 von 0,50 auf 0,49 Prozent reduziert. Der Schritt fällt auf den ersten Blick winzig aus, hat aber eine besondere Bedeutung, denn mit 0,49 Prozent rutscht die Position unter die Schwelle von 0,50 Prozent. [mehr]

Market DNA: DACH Geos Unpacked

DACH is a major Tier-1 region with high competition among iGaming brands and a demanding audience.In DACH, a strong offer is not enough: users evaluate the entire journey to the deposit, so the product must meet local expectations in terms of payments, onboarding, content, and CRM.In the new Market DNA series, N1 Partners (https://n1.partners/?utm_campaign=media&utm_source=web&utm_medium=igamingnews&utm_content=marketdna_dach) examines each region from two perspectives at once: how the platfo...

Hostinger brings the full online journey into the agentic era with AI Builder

As AI is collapsing the boundaries of online creation, Hostinger brings building, running, and growing online into one agentic experience with AI Builder. As AI is collapsing the boundaries of online creation, Hostinger brings building, running, and growing online into one agentic experience with AI Builder.

Memodyne Introduces a Transparent, Once-Daily Cognitive Support Formula

Memodyne provides information about its dietary supplement formula, including individual ingredients, serving instructions, and product labeling details. Memodyne provides information about its dietary supplement formula, including individual ingredients, serving instructions, and product labeling details.

PRE Posts Blockbuster Results

By Brad Sorensen, CFANASDAQ: PREREAD THE FULL PRE RESEARCH REPORTPrenetics Global Limited’s (NASDAQ: PRE) second-quarter 2026 investor update may represent the most important quarterly report since the launch of IM8. The headline numbers are impressive—rapid revenue growth, another record quarter, accelerating subscription adoption and substantially higher full-year guidance—but the most significant development in our view is underneath the revenue line. Prenetics has now demonstrated that t...

Biochips Market to Grow from USD 14.01 Billion in 2025 to USD 21.36 Billion by 2030, at a CAGR of 8.8% - MarketsandMarkets™

Delray Beach, FL , Aug. 18, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global biochips market to reach USD 21.36 billion by 2030 from USD 14.01 billion in 2025, growing at a CAGR of 8.8% during the forecast period. Market growth is driven by increasing demand for personalized medicine and the rising focus on precision diagnostics. The growing prevalence of chronic and infectious diseases, expanding applications in drug discovery, genomics, and proteomics, and increasing emphasis ...

NORMA Group Aktie mit neuem Hoffnungssignal: Citadels Rückzug könnte die Kräfte neu verteilen

Bad Marienberg (www.aktiencheck.de) - Bei der NORMA Group-Aktie sendet einer der bekanntesten Hedgefonds ein bemerkenswertes Signal: Citadel Advisors hat seine Netto-Leerverkaufsposition am 17. August 2026 von 0,79 auf 0,67 Prozent reduziert. Der Schritt fällt deutlich aus und könnte für Anleger interessanter sein, als es die scheinbar kleinen Prozentzahlen zunächst vermuten lassen. [mehr]